동의생리병리학회지 (Journal of Physiology & Pathology in Korean Medicine)

  • 제35권6호
  • /
  • Pages.255-260
  • /
  • 2021
  • /
  • 1738-7698(pISSN)
  • /
  • 2288-2529(eISSN)
대한동의생리학회·한의병리학회 ( The Physiological Society of Korean Medicine and The Society of Pathology in Korean Medicine)
권호 표지
DOI QR코드

DOI QR Code

진무탕으로 임상적 관해가 유도된 크론병 환자: 증례보고

Clinical Remission of Crohn's Disease Induced by Herbal Decoction (Jinmoo-tang): A Case Report

  • 이병희 (한걸음한의원) ;
  • 원지윤 (경희대학교 대학원 기초한의과학과) ;
  • 이향숙 (경희대학교 대학원 기초한의과학과)
  • Lee, Byunghee (Hanstep Korean Medicine Clinic) ;
  • Won, Jiyoon (Department of Korean Medical Science, Graduate School, Kyung Hee University) ;
  • Lee, Hyangsook (Department of Korean Medical Science, Graduate School, Kyung Hee University)
  • 투고 : 2021.05.14
  • 심사 : 2021.11.02
  • 발행 : 2021.12.25
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Crohn's disease (CD) is an idiopathic inflammatory bowel disease (IBD) with unknown etiopathogenesis. Currently there are no definitive treatment modalities for CD. This case report presents clinical remission and its maintenance of CD induced by Korean herbal medicine treatment. A 56-year-old male patient diagnosed as CD by capsule endoscopy presented to a Korean Medicine clinic with severe abdominal pain as a chief complaint. Despite taking 5-aminosalicylic acid and immunosuppressant for 2 years, his abdominal pain was worsening at the time of visit. Treatment was initiated with Jinmoo-tang based on pattern identification and continued for approximately a year with some modifications according to patient's symptom changes. He was mainly given Jinmoo-Tang for a year and clinical remission was achieved; he could stop taking western medications. For 6 years since then, he took Korean medicine from time to time when he felt his condition went down and he is still maintaining remission. There were no adverse events reported. This case report suggests that individualized Korean herbal medicine treatment may have the potential for induction and maintenance of clinical remission of CD. Further research is warranted to establish an evidence-base for such approach.

키워드

참고문헌

  1. Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE. ACG Clinical Guideline: Management of Crohn's Disease in Adults. Am J Gastroenterol. 2018;113(4):481-517. https://doi.org/10.1038/ajg.2018.27
  2. Kwak MS, Cha JM, Lee HH, Choi YS, Seo SI, Ko KJ, et al. Emerging trends of inflammatory bowel disease in South Korea: A nationwide population-based study. J Gastroenterol Hepatol. 2018.
  3. Ng WK, Wong SH, Ng SC. Changing epidemiological trends of inflammatory bowel disease in Asia. Intest Res. 2016;14(2):111-9. https://doi.org/10.5217/ir.2016.14.2.111
  4. Park JJ, Yang SK, Ye BD, Kim JW, Park DI, Yoon H, et al. Second Korean Guidelines for the Management of Crohn's Disease. Korean J Gastroenterol. 2017;69(1):29-54. https://doi.org/10.4166/kjg.2017.69.1.29
  5. Wehkamp J, Gotz M, Herrlinger K, Steurer W, Stange EF. Inflammatory Bowel Disease. Dtsch Arztebl Int. 2016;113(5):72-82.
  6. Papamichael K, Lin S, Moore M, Papaioannou G, Sattler L, Cheifetz AS. Infliximab in inflammatory bowel disease. Ther Adv Chronic Dis. 2019;10:2040622319838443. https://doi.org/10.1177/2040622319838443
  7. Choi CW, Son CG, Cho CK. The oriental-western literal study of Crohn's disease. Journal of Daejeon University Research Institute of Korean Medicine. 2001;9(2):251-68.
  8. Lee MS, Hwang MW, Kim YH. A Case Study of a Soyangin Patient with Crohn's Disease who Reported Symptomatic Improvement after Being Treated with Dojeokgangki-tang. Journal of Sasang Constitutional Medicine. 2012;24(2):61-70. https://doi.org/10.7730/JSCM.2012.24.2.061
  9. Na WG, Yang MR, Lee HJ, Park EJ. A case report of Crohn's disease. Journal of Korean Oriental Pediatrics. 2002;16(2):51-8.
  10. Kim SW, Lee OJ, Shin JC. A Case Study of a Crohn's Disease Patient Treated with Oriental Medical Treatment. Korean J Acupunct. 2014;31(4):247-52. https://doi.org/10.14406/acu.2014.035
  11. Seo SH, Jeong JO, Lee EJ, Choi IS, Park SE, Kim WI, et al. A Case Study of Suspected Crohn's Disease Treated with Bojanggunbitang. The Journal of Internal Korean Medicine. 2004;25(3):648-54.
  12. Park JM, Kim HJ, Keum DH, Park YH, Lee MJ. The effect of Oriental Medical Treatment on Crohn's disease; 1 Case Report. The Journal of Chuna Manual Medicine for Spine & Nerves. 2010;5(1):57-66.
  13. Lee BH, Won JY, Park JR, Lee HS. Remissions of Crohn's Disease at Onset and Relapse Using Herbal Medicine: A Case Report. Korean J Acupunct. 2020;37(3):183-90. https://doi.org/10.14406/acu.2020.019
  14. Joos S, Rosemann T, Szecsenyi J, Hahn EG, Willich SN, Brinkhaus B. Use of complementary and alternative medicine in Germany - a survey of patients with inflammatory bowel disease. BMC Complement Altern Med. 2006;6:19. https://doi.org/10.1186/1472-6882-6-19
  15. Hilsden RJ, Verhoef MJ, Rasmussen H, Porcino A, DeBruyn JC. Use of complementary and alternative medicine by patients with inflammatory bowel disease. Inflamm Bowel Dis. 2011;17(2):655-62. https://doi.org/10.1002/ibd.21360
  16. Abitbol V, Lahmek P, Buisson A, Olympie A, Poupardin C, Chaussade S, et al. Impact of complementary and alternative medicine on the quality of life in inflammatory bowel disease: results from a French national survey. Eur J Gastroenterol Hepatol. 2014;26(3):288-94. https://doi.org/10.1097/MEG.0000000000000040
  17. Best WR, Becktel JM, Singleton JW, Kern F, Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976;70(3):439-44. https://doi.org/10.1016/s0016-5085(76)80163-1
  18. Todo Y, Kim JO. Yakjing 1st ed. Kyonggi-do: Mulgogisoop; 2014.
  19. Park JH KH, Seo BI. A philological study on poisoning of Ephedrae Herba. The Journal of Ease-West Medicine. 2012.
  20. Martins NB, Peppercorn MA. Inflammatory bowel disease. Am J Manag Care. 2004;10(8):544-52.
  21. Knyazev OV, Kagramanova AV, Korneeva IA, Noskova KK, Belousov SV, Parfenov AI. The use of fecal calprotectin in monitoring activity of inflammatory bowel diseases. Ter Arkh. 2019;91(4):53-61.
  22. Horiba Y, Yoshino T, Watanabe K. Kampo Extract of Shinbuto Improved Refractory Diarrhea in Milroy's Disease. Glob Adv Health Med. 2013;2(1):14-7. https://doi.org/10.7453/gahmj.2013.2.1.003
  23. Won JY, Lee BH, Jung WM, Chae YB, Lee HS. Herbal medicine for inflammatory bowel diseases: development of pattern identification algorithms by retrospective analysis of case series data. Eur J Integr Med. 2020;36:101114. https://doi.org/10.1016/j.eujim.2020.101114
  24. Lee JG YC. The study on chemical components and Korean medical effects of Poria cocos. The Journal of Jeahan Oriental Medical Academy. 2015.
  25. Liu X, Yu X, Xu X, Zhang X, Zhang X. The protective effects of Poria cocos-derived polysaccharide CMP33 against IBD in mice and its molecular mechanism. Food Funct. 2018;9(11):5936-49. https://doi.org/10.1039/C8FO01604F
  26. Han KH, Park JM, Jeong M, Han YM, Go EJ, Park J, et al. Heme Oxygenase-1 Induction and Anti-inflammatory Actions of Atractylodes macrocephala and Taraxacum herba Extracts Prevented Colitis and Was More Effective than Sulfasalazine in Preventing Relapse. Gut Liver. 2017;11(5):655-66. https://doi.org/10.5009/gnl16496
  27. Zhang L, Wei W. Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony. Pharmacol Ther. 2020;207:107452. https://doi.org/10.1016/j.pharmthera.2019.107452
  28. Yoo CK, Kwon KR. The Bibilographic studies on Aconiti Ciliare Tuber and Radix Aconiti. J Pharmacopunct. 2001;4(2):87-93. https://doi.org/10.3831/KPI.2001.4.2.087
  29. Wang X, Wang G, Shang J, Pan H, Zhang XA, Zhou F. Immunosuppressive therapies adversely affect blood biochemical parameters in patients with inflammatory bowel disease: a meta-analysis. J Int Med Res. 2019;47(8):3534-49. https://doi.org/10.1177/0300060519864800